SIBN - SI-BONE Inc Stock Price, Fair Value and News

$13.25+0.20 (+1.53%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

SIBN Price Action

Last 7 days

-1.3%

Last 30 days

9.0%

Last 90 days

-13.9%

Trailing 12 Months

-37.2%

SIBN RSI Chart

SIBN Valuation

Market Cap

555.7M

Price/Earnings (Trailing)

-14.86

Price/Sales (Trailing)

3.54

Price/Free Cashflow

-22.03

SIBN Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

SIBN Fundamentals

SIBN Revenue

Revenue (TTM)

157.0M

Rev. Growth (Yr)

18.6%

Rev. Growth (Qtr)

0.93%

SIBN Earnings

Earnings (TTM)

-37.4M

Earnings Growth (Yr)

34.39%

Earnings Growth (Qtr)

26.45%

SIBN Profitability

Return on Equity

-22.67%

Return on Assets

-16.48%

Free Cashflow Yield

-4.54%

SIBN Investor Care

Shares Dilution (1Y)

3.55%

Diluted EPS (TTM)

-0.91

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	144.0M	150.7M	157.0M	0
2023	116.7M	124.4M	132.0M	138.9M
2022	92.1M	95.5M	99.7M	106.4M
2021	77.0M	85.2M	87.1M	90.2M
2020	69.1M	66.9M	71.1M	73.4M
2019	57.7M	60.3M	63.1M	67.3M
2018	49.8M	51.7M	53.5M	55.4M
2017	0	0	0	48.0M

Get all data in R, Python etc through our Historical Stock Data APIs

About SI-BONE Inc

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and distributors. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

CEO	Ms. Laura A. Francis MBA
WEBSITE	https://si-bone.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	357

SI-BONE Inc Frequently Asked Questions

What is the ticker symbol for SI-BONE Inc? What does SIBN stand for in stocks?

SIBN is the stock ticker symbol of SI-BONE Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of SI-BONE Inc (SIBN)?

As of Fri Dec 20 2024, market cap of SI-BONE Inc is 555.68 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SIBN stock?

You can check SIBN's fair value in chart for subscribers.

Is SI-BONE Inc a good stock to buy?

The fair value guage provides a quick view whether SIBN is over valued or under valued. Whether SI-BONE Inc is cheap or expensive depends on the assumptions which impact SI-BONE Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SIBN.

What is SI-BONE Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, SIBN's PE ratio (Price to Earnings) is -14.86 and Price to Sales (PS) ratio is 3.54. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SIBN PE ratio will change depending on the future growth rate expectations of investors.